AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06455527 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Direct Current Stimulation (tDCS)
Description: Sham tDCS will be delivered using the 1x1 Mini CT tDCS device. For sham tDCS, the device is programmed to ramp up to 2.0 mA (for 30 seconds) followed by a ramp down (30 seconds), with no current delivery for 28 minutes, and then ramp up (for 30 seconds) and down (for 30 seconds) at the end. Participants will receive 10 sessions of sham tDCS over the course of this study on weekdays (M-F).
Study NCT05127447 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ES application
Description: Electrical stimulation (ES) application will be given to the ES group
Study NCT05127447 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham application
Description: Only vacuum was applied and no current was given from the applied device
Study NCT05630612 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sparsentan
Description: 6 weeks of treatment with sparsentan or irbesartan. This will be administered in a double-blind fashion.
Study NCT05630612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sparsentan
Description: 6 weeks of treatment with sparsentan or irbesartan. This will be administered in a double-blind fashion.
Study NCT05237908 — intervention group
Intervention type: DEVICE
Intervention: Transforaminal Lumbar Interbody Fusion
Description: Interbody Fusion means the operative immobilization or ankylosis of two or more vertebrae by fusion of the vertebral bodies with a short bone graft or often with diskectomy or laminectomy. (From Blauvelt and Nelson, A Manual of Orthopaedic Terminology, 5th ed, p236; Dorland, 28th ed
Study NCT04183023 — intervention group
Intervention type: GENETIC
Intervention: Collection of a salivary sample
Description: Volunteers who agreed to participate will have to collect their saliva with the self-collection device. They will then send back their saliva sample and a dated and signed copy of the informed consent form in the pre-paid return envelope.~All DNA of the saliva samples will be automatically extracted, then DNA samples will be genotyped and 4,000 of them will be sequenced.~The genotyping will consist of measurement of general genetic variation, including the Single Nucleotide Polymorphisms. The SNP genotyping will be carried out using Illumina high density chips, in CNRGH production platform.~A subset of 4,000 individuals will be selected to provide a homogeneous geographic coverage and to avoid inclusion of related individuals who will share large genomic regions. Sequencing will be performed in order to reach a mean coverage of 30X for each sample and a minimum of 25X mean coverage.~Finally, a bioinformatics analysis will be performed on sequencing data.
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Water (reference)
Description: Ingestion of 500 ml mineral water
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sucrose
Description: Ingestion of 500 ml of a flavored mineral water sweetened with sucrose
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Sucralose
Description: Ingestion of 500 ml of a flavored mineral water sweetened with sucralose
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Stevia
Description: Ingestion of 500 ml of a flavored mineral water sweetened with stevia extract
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Monk fruit
Description: Ingestion of 500 ml of a flavored mineral water sweetened with monk fruit extract
Study NCT05575687 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Allulose + stevia
Description: Ingestion of 500 ml of a flavored mineral water sweetened with allulose and stevia extract
Study NCT06038747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-Monitoring
Description: The post-session battery consists of two self-report scales measuring both positive and negative affective reactions of the participants toward their therapist during the therapy session. The general feedback is a brief text that encourages participants to share and discuss their feelings and reflections with their therapist.
Study NCT06038747 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Individual Psychotherapy
Description: Individual psychotherapy sessions
Study NCT06038747 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individual Psychotherapy
Description: Individual psychotherapy sessions
Study NCT04909619 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral suprazygomatic maxillary nerve block
Description: The maxillary nerve, V2, is purely a sensory branch of the trigeminal nerve. V2 exits the skull through the foramen rotundum and courses through the pterygopalatine fossa, a small pyramid-shaped depression located posterior to the maxilla. As the maxillary nerve exits the pterygopalatine fossa, it divides into numerous branches that supply sensation to the posterior nasal cavity, palate, sinuses, and maxilla. It is within the pterygopalatine fossa that the maxillary nerve is targeted and anesthetized during the block. With the patient in the supine position after nasotracheal intubation, a needle is inserted perpendicularly between the upper border of the zygomatic arch and posterior orbital rim until it reaches the greater wing of the sphenoid, where the needle is then retracted by a few millimeters and redirected toward the nasolabial fold until it hits the pterygopalatine fossa.
Study NCT04909619 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthetic infiltration of the palate
Description: Local anesthetic infiltration of the palate during cleft palate repair is universally practiced. The benefits of local anesthetic infiltration are twofold: to provide anesthesia to the terminal branches of the nasopalatine and greater palatine nerves that are in the immediate area of the injection sites and to achieve hemostasis during closure when the medication is mixed with epinephrine. To administer local anesthetic infiltration of the palate, a 25 gauge needle is inserted next to the incision into the soft tissue. The tissue is first aspirated to determine safety of injection at that site. The medication is then injected parallel to the incision on both sides.
Study NCT04756271 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-Cov-2 neutralizing antibody titer
Description: Quantitation of SARS-Cov-2 antibody titer at baseline after each dose of the vaccine
Study NCT05841615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Renal Denervation operation
Description: RDN: Percutaneous renal artery sympathetic radiofrequency ablation for both sides. For each side, a total of 13 targets were ablated. The ablation power was 8W\~12W for 40 seconds
Study NCT06309251 — intervention group
Intervention type: OTHER
Intervention: ketogenic diet (as per clinical practice)
Description: Patients recruited receive a ketogenic diet. The prescription, the type of KD protocol and the route of administration will depend, essentially, on the patient's ability and willingness to feed spontaneously and independently, as well as on compliance with the therapies set and the severity of the clinical conditions.
Study NCT06647459 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EP Study
Description: To use programmed ventricular stimulation at the time of AF ablation to define the prevalence and mechanism of inducible ventricular tachycardia (VT); pace-mapping to define the site of origin of ventricular arrhythmias; and voltage mapping to define low voltage scar substrate in the basal LV in patients with pathogenic TTN variants compared to genotype-negative controls.
Study NCT06274723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expert
Description: Participants will view a brief description of an expert source.
Study NCT06274723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer
Description: Participants will view a brief description of a peer source.
Study NCT06274723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1 Sided
Description: Participants will view e-cigarette education messages in one-sided.
Study NCT06274723 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 2 Sided
Description: Participants will view e-cigarette education messages in two-sided.
Study NCT05603052 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EuCorVac-19
Description: COVID-19 vaccine
Study NCT05603052 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ChAdOx1 nCoV-19
Description: COVID-19 vaccine
Study NCT04863248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trilaciclib
Description: Trilaciclib administered IV over 30 minutes prior to docetaxel IV on Day 1 of each 21-day cycle.
Study NCT04863248 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered IV over 30 minutes prior to docetaxel IV on Day 1 of each 21-day cycle.
Study NCT04863248 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Docetaxel
Description: Docetaxel administered IV on Day 1 of each 21-day cycle.
Study NCT04863248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Docetaxel administered IV on Day 1 of each 21-day cycle.
Study NCT05756114 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Support Group
Description: Support Group condition, meetings will be held online via HIPAA-compliant Zoom and run by a trained SMART Recovery meeting facilitator
Study NCT05756114 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducational Email
Description: Participants receive a weekly email with a Qualtrics survey link containing psychoeducational content.
Study NCT05192629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Premedication by intranasal dexmedetomidine
Study NCT05841615 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Pulmonary vein isolation
Description: PVI: Pulmonary vein isolation was performed until the potential of each pulmonary vein disappeared under the guidance of the CARTO mapping system. Ablation of the top line and the bottom line of the left atrium was performed at the same time.
Study NCT05841615 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Description: PVI: Pulmonary vein isolation was performed until the potential of each pulmonary vein disappeared under the guidance of the CARTO mapping system. Ablation of the top line and the bottom line of the left atrium was performed at the same time.
Study NCT05192629 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Premedication by intranasal midazolam
Study NCT05830656 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to nearby nature
Description: Participants spend a minimum of 20 minutes in their favourite place in nearby nature.
Study NCT05830656 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to virtual nature
Description: Participants spend a minimum of 20 minutes watching virtual nature videos.
Study NCT05924750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-M11D1
Description: Administration by intravenous infusion
Study NCT06395974 — intervention group
Intervention type: OTHER
Intervention: fetal ultrasound
Description: 2D, 3D , Doppler ultrasound
Study NCT05727631 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gentle human touch
Description: Mother will apply gentle human touch touch technique during venous blood collection from preterm babies between 32-37 weeks of gestation
Study NCT06605235 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local Anesthesia
Description: In Group A, patients received 20 ml of 1% lignocaine (Xyloaid-lignocaine HCl injection) infiltrated in the gall bladder bed after removal of the gall bladder, along with 10 ml of 1% lignocaine infiltration at the port sites at the end of the procedure. Subjects in Group B received 20 ml of 0.25% bupivacaine (Bupicain-Bupivacaine HCl injection) infiltration in gall bladder bed, along with 10 ml of 0.25% bupivacaine at port sites. In Group C patients received 10 ml of 1% lignocaine along with 10 ml of 0.25% bupivacaine infiltrated in gall bladder bed, and then 5 ml of 1% lignocaine along with 5 ml of 0.25% bupivacaine at the port sites
Study NCT06605261 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga (intervention) group
Description: The yoga (intervention) group comprises 64 women with breast cancer who have been randomly assigned and are undergoing endocrine therapy. To alleviate arthralgia and vasomotor symptoms (hot flashes, night sweats), a structured yoga program will be administered during the initial months of endocrine therapy, consisting of 60-minute sessions, 4 days per week, for a duration of one month.
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT05748977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SABA SAMA ICS Vs LABA LAMA ICs
Description: Short acting agents,long acting agents ,ics
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood
Study NCT04906733 — intervention group
Intervention type: PROCEDURE
Intervention: Tumor biopsy
Description: Patients with RAS/RAF wild-type metastatic right colon cancer will receive biopsy before the standard treatment of chemotherapy or target therapy.
Study NCT06446830 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: multimodal analgesia and vitamin B
Description: B1, B6 , B9 , B12 in addition to the routine paracetamol and NSAID
Study NCT06446830 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: standard multimodal analgesia
Description: Routine Paracetamol and NSAID
Study NCT06269406 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ibuprofen 400 mg in combination with Curcumin covered with liquorice root 100 mg
Description: The combination of ibuprofen 400 mg and Curcumin covered with liquorice root 100 mg in patients after 2-4 molars procedure
Study NCT06269406 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ibuprofen 200 mg in combination with Curcumin covered with liquorice root 100 mg
Description: The combination of ibuprofen 200 mg and Curcumin covered with liquorice root 100 mg in patients after 2-4 molars procedure
Study NCT06269406 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: The combination of ibuprofen 400 mg and placebo in patients after 2-4 molars procedure
Description: The combination of ibuprofen 400 mg and placebo 100 mg in patients after 2-4 molars procedure
Study NCT04739800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cediranib Maleate
Description: Given PO
Study NCT05968794 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vaginal cerclage
Description: A vaginal cerclage is a short and minor surgical procedure performed under general or regional anesthesia. An unabsorbable suture is placed around/through the cervix to close the cervical canal and to increase its firmness, in order to reduce cervical insufficiency.
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography with Contrast
Description: Undergo CT with contrast
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography with Contrast
Description: Undergo CT with contrast
Study NCT04739800 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05821868 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dosivent
Description: Dosivent® inhalation chamber is designed to optimize the delivery of inhaled bronchodilators and corticosteroids in the treatment of respiratory diseases
Study NCT05719415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Measurement of pulmonary functional capillary surface area
Description: Measurement of transpulmonary metabolism of trace injected doses of benzoyl-Phe-Ala-Pro
Study NCT05821868 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aerochamber Plus Flow Vu
Description: Aerochamber Plus Flow Vu® inhalation chamber is also designed to optimize the delivery of inhaled bronchodilators and corticosteroids in the treatment of respiratory diseases
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA
Study NCT04739800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA
Study NCT04739800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olaparib
Description: Given PO
Study NCT04739800 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Given IV
Study NCT04739800 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pegylated Liposomal Doxorubicin Hydrochloride
Description: Given IV
Study NCT04739800 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan Hydrochloride
Description: Given IV
Study NCT06607848 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low-Add EDOF IOL
Description: Acunex Vario AN6V
Study NCT06607848 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EDOF IOL
Description: PureSee EDOF IOL
Study NCT06608628 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Experimental Group
Description: The experimental group students will play a patient safety escape room game. Control group students will be given traditional education. The knowledge level and team cooperation of the two groups will be compared.
Study NCT06608628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: The experimental group students will play a patient safety escape room game. Control group students will be given traditional education. The knowledge level and team cooperation of the two groups will be compared.
Study NCT06608784 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiography
Description: 12-lead electrocardiography
Study NCT06037785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Paced Self-Management (SPSM)
Description: (SPSM) consists of two components: 1) HR Self-monitoring, and 2) online Shock Management modules (N=4) with weekly telephone coaching, completed over 1 month.
Study NCT06609018 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lenses (stenfilcon A)
Description: Daily disposable, soft contact lenses worn for one week
Study NCT06609018 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control Lenses (omafilcon A)
Description: Daily disposable, soft contact lenses worn for one week
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Cognitive skills test
Description: Cognitive skills; It will be evaluated with the Montreal Cognitive Assessment Scale.
Study NCT06606665 — intervention group
Intervention type: OTHER
Intervention: Reaction time test
Description: Reaction time; It will be evaluated with the 12-Red Square Test on the App-coo test application via tablet.
Study NCT05219526 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: blood glucose measurement: BGM
Description: measurement of blood glucose concentration using different BGM
Study NCT05219526 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: blood glucose measurement: reference method
Description: measurement of blood glucose concentration using reference Method
Study NCT04778722 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral probiotics
Description: containing four Lactobacillus strains (Lactobacillus crispatus -Lbv88, Lactobacillus rhamnosus -Lbv96, Lactobacillus jensenii -Lbv116, and Lactobacillus gasseri -Lbv150)
Study NCT06209645 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS (Transcranial Direct Current Stimulation)
Description: The tDCS group will be treated with non-invasive motor cortex stimulation. A two-minute EEG recording will be made before each session, using the same electrodes as for stimulation. Anodal stimulation of 2,0 mA will be delivered over the motor area contralateral to the painful region (C4 or C3 according to the international 10-20 system). The return electrode will be placed over the fronto-polar region (FP1 or FP2) ipsilateral to the painful region. If pain is bilateral, the most painful region will be chosen to be treated.